YungShin Global Holding Corporation (TPE:3705)

Market Cap	15.61B
Revenue (ttm)	8.56B
Net Income (ttm)	986.30M
Shares Out	266.36M
EPS (ttm)	3.70
PE Ratio	15.84
Forward PE	n/a
Dividend	3.00 (5.12%)
Ex-Dividend Date	Jun 24, 2025

Volume	517,357
Average Volume	734,511
Open	58.40
Previous Close	58.20
Day's Range	58.00 - 59.00
52-Week Range	51.90 - 69.90
Beta	0.12
RSI	57.82
Earnings Date	Nov 11, 2025

About YungShin Global Holding

YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics. The company is also involved in trade, investment, and other related businesses; import and export trading; and sale of medicine. It has operations in Taiwan, the United States, Mainland China, and Japan. The company was incorporated in 2011 and is headquartered in Taipei City, Taiwan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2011
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3705

Financial Performance

In 2024, YungShin Global Holding's revenue was 8.03 billion, an increase of 14.29% compared to the previous year's 7.03 billion. Earnings were 1.17 billion, an increase of 41.24%.